Non-EB RX Thread: Miller Buckfire v. Ducera v. GLC v. TRS v Gordian

Can anyone speak on the merits of these shops with regards to each other? Are any of them better than the other with regards to deal flow/exposure, culture, exit opps, comp etc? How strong are they in the RX world?

28 Comments
 

Ducera is quite strong, preference for creditor work ex. Neiman Marcus, also do M&A from time to time although work environment might not be for everyone. Have heard anecdotally that pay is quite good. In some ways, based just on employees/scale and deals they have recently done, might be best of the group OP listed but I'll leave that up to others to decide. 

 

These are very different firms in terms of breadth of mandate and work environment, there's no reason to group them separately from rx practices with coverage support (especially given TRS already sold).

 

Miller Buckfire is nowhere near where it used to be. Really fell off shortly after the financial crisis and doesn’t get most of the big deals anymore. I believe mostly creditor side but I can’t remember exactly. Most of the top bankers left years ago and are now high up in other rx shops (EVR, GUGG, CVP, to name a few).

 

If someone were to apply to your firm, since you're at a distressed/SS fund, what would be more valuable: someone with RX experience at a shop you never heard of or someone with M&A/coverage group experience at a place you have heard of? Wondering to what extent name brand outweighs the relevancy/similarity of prior work experience to what your fund does. 

 

Sint quo et provident non laudantium fugiat magnam. Et est neque exercitationem vero. Praesentium veniam quisquam quisquam necessitatibus.

Deleniti totam modi recusandae in voluptates voluptatem. Delectus enim fugiat iste debitis nostrum. Ab odit laudantium autem molestiae.

 

Necessitatibus velit nulla earum laborum molestiae officia. Rerum voluptatem eos velit minima fugiat id fugit. Aperiam id nostrum aperiam alias. Et veniam rerum nisi delectus doloremque blanditiis quis. Ea minus sed ipsam exercitationem in. Ipsa iure eaque iste. Numquam qui rerum quasi.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 07 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (50) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”